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ABSTRACT
Objectives: The objective of the study is to determine efficacy of the Primary Prevention Program of Neural Tube Defects 
in Polish women with higher education in 5-year interval.
Material and methods: Survey research was conducted twice (in 2008 and 2013) in 630 female students of universities: 
305 female medical students and 325 female non-medical students. The survey was also done among women aged 27– 
–35 who graduated from medical or non-medical universities and have at least one child. Questions concerned knowledge 
about prophylaxis and periconceptional folic acid intake. Chi square test was used to assess the significance.
Results: Knowledge concerning prophylaxis was significantly higher in female medical students comparing to non-medical 
ones, both in 2008 (p < 0,001), and in 2013 (p < 0,001). 92.9% in 2008 and 93.9% in 2013 of medical students knew about 
the necessity of periconceptional folic acid intake. Awareness of female non-medical students was lower (2008 — 35.3% 
and 2013 — 41.1%) and did not change in the 5-year long period (p = 0.3).
There was no significant difference in preconceptional folic acid intake among mothers with medical and non-medical 
education (53.3% vs. 45% p = 0.4). However, the highest folic acid intake was among mothers –medical doctors who treat 
children with neural tube defect.
Conclusions: Difference between medical and non-medical students shows that better educational programs may improve 
knowledge about prophylaxis. Aside from knowledge, compliance with recommendations of Primary Prevention Program 
of Neural Tube Defects is unsatisfactory.
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INTRODUCTION
Neural tube defect (NTD) is one of the most common 
and most severe congenital malformations affecting child 
development. They present with urination and defecation 
disorders, paresis and limb paralysis. Hydrocephalus and 
lower limbs’ deformation may often be the consequence of 
such defect. Due to limited treatment potential, the signifi-
cance of prophylaxis is high. In 1980 Smithells from Leeds 
(UK) showed that a supplementary intake of 0.4 [mg] of folic 
acid before and at the beginning of pregnancy significantly 
reduces incidence of NTD [1]. This finding was confirmed 
by numerous clinical studies conducted at large female 
populations (over 250 000 subjects). A multicenter research 
performed by MRC Vitamin Study Research Group (1991) in 
1817 women from 33 countries that had high risk of NTD in 
a child due to previously affected pregnancy showed that 
periconceptional folic acid intake reduces occurrence of 
NTD by 72% [2]. 
Similarly, other studies have revealed that the supplemen-
tation of folate 4 weeks prior to conception and throughout 
the first trimester pregnancy is effective in NTD prophylaxis 
also in women with a negative NTD family history [3, 4]. 
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Seremak-Mrozikiewicz has demonstrated that active 
form of folate (metafolin) may be efficiently used in NTD 
prophylaxis in women who are carriers of mutated vari-
ants of polymorphic genes for enzymes involved in folate 
metabolism [5]. 
Today there is evidence that folic acid supplementation 
reduces occurrence of some other congenital malformations 
as well, including heart defects, cleft lip and palate, urinary 
and gastrointestinal tract malformations [6–8].
Moreover, folic acid intake decreases the risk of obstetric 
complications such as pre-eclampsia, spontaneous abortion, 
preterm delivery or delivery of small-for-gestational-age neo-
nate [9, 10]. A low blood level of folate in pregnant women 
is associated with increased incidence of neurodevelopmen-
tal disorders in children [11, 12]. Meta-analysis by Goh et al. 
showed that the use of multivitamin preparations with folic 
acid by pregnant women reduces occurrence of cancer in their 
children (leukemia, brain cancer and neuroblastoma) [13]. 
In 1997 Polish Gynecological Society introduced Primary 
Prevention Program of Neural Tube Defects that involves 
supplementation of folic acid. The aim of this project is to 
popularize intake of 0.4 [mg] of folic acid by all women who 
may potentially become pregnant and to spread knowledge 
about primary prophylaxis of NTD in the society. According 
to the Polish Gynecological Society Expert Group (2011) the 
supplementation should be started at least 6 weeks before 
planned conception and should be continued until the 
second trimester of pregnancy [14].
OBJECTIVES
The objective of this paper is to determine the efficacy 
of the Primary Prevention Program of NTDs in women with 
higher education in Łódź- the third largest city in Poland 
(with regard to population). The survey research was con-
ducted twice: in 2008 and in 2013.
MATERIAL AND METHODS
The survey was conducted in Łódź - the third largest 
city in Poland (with regard to population). From a total of 
22 higher education institutions (6 public and 16 non-public) 
in the city we selected 3 biggest institutions, namely: Medi-
cal University of Łódź, Technical University of Łódź and Uni-
versity of Łódź.
The research included the following groups of women: 
630 female medical and non-medical students, 120 young 
women with higher education who have at least one child 
and 81 mothers of neonates born with NTD.
Female students of medical  
and non-medical faculties
The survey among a total of 630 medical and non-medical 
students was conducted twice: in 2008 and in 2013. Subjects 
were divided into two groups. The first group (305 women) 
comprised female medical students (faculties of medicine, 
dentistry and pharmacy of Medical University of Łódź). The 
second group (325 women) comprised female non-medical 
students (faculties of civil engineering, architecture and 
environmental engineering of Technical University of Łódź 
and faculties of economics and sociology of University of 
Łódź). The survey was conducted at the end of lectures and 
random sampling selected every third student.
Answers were collected personally with a direct inter-
view by investigators educated in the field of pediatrics 
and neonatology. To minimize the interviewer bias, three 
interviewers were involved and used unified rules of ask-
ing questions and interpreting the answers. Students were 
asked about primary prophylaxis of NTDs. The answer was 
considered correct when the student recognized that pri-
mary prophylaxis of NTDs involves periconceptional intake 
of folic acid, regardless of its form. 
Women with medical and non-medical higher 
education who have at least one child
The study included also females aged 27–35 that are 
mothers to at least one child and who graduated from one of 
the universities in Łódź. A group of 60 mothers were gradu-
ates of Medical University of Łódź and worked as medical 
doctors (residents) in the Polish Mother’s Memorial Hospital 
Research Institute in Łódź. They were interviewed at the end 
of lectures for residents (obligatory classes during the train-
ing program in pediatrics, neonatology, gynecology and 
obstetrics, not related to folic acid topic). Another group of 
60 mothers were graduates of Technical University of Łódź 
and the University of Łódź and they were interviewed at 
kindergartens in Łódź. Every third mother with an adequate 
education was selected by random sampling for the survey. 
All mothers (with medical or non-medical higher education) 
were asked personally if they had taken folic acid 6 weeks 
before conception and during the pregnancy. Women who 
were not sure about timing of their folic acid supplementa-
tion were excluded from the study.
The group of mothers with medical higher education 
included female doctors (n = 9) who worked at the De-
partment of Intensive Care and Congenital Malformations 
of Newborns and Infants where neonates with NTDs are 
treated. They were asked if they had taken folic acid 6 weeks 
before conception and during the pregnancy. They were 
also asked if their pregnancy had started before or after 
they began working at the department. 
Mothers of neonates born with the NTD
Finally, the last group included in the survey was that 
of 81 mothers of neonates with NTD that were treated be-
tween 2004 and 2015 at the Department of Intensive Care 
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and Congenital Malformations of Newborns and Infants 
of the Polish Mother’s Memorial Hospital Research Insti-
tute (the only treatment center of NTDs in Łódź province). 
The respondents were divided into two groups: mothers of 
neonates born between 2004–2009 (n = 50) and mothers of 
neonates born between 2010–2015 (n = 31). An investigator 
conducted the survey personally or by phone. 
Statistical calculations were performed using Statistica 
(version 12) software of Stat Soft. A chi-square test was 
used. The results were regarded as statistically significant 
if p < 0.05.
All data was collected with the approval of the Institu-
tional Review Board of the Polish Mother’s Memorial Hos-
pital Research Institute in Łódź in Poland.
RESULTS
Female students of medical  
and non-medical faculties
The analysis of the survey has showed that in the year 
2008 the knowledge about NTD prophylaxis was significant-
ly more common in the group of female medical students 
compared to non-medical ones (92.1% vs. 38% p < 0,001) 
(Figure  1). Compared to repeated survey 5 years later in 
2013, the awareness of medical students remained signifi-
cantly higher than non-medical students (93.3% vs. 57.1% 
p < 0,001). Also, the level of knowledge did not change 
significantly over the 5 years interval (2008–2013) between 
medical (p = 0.7) and non-medical (p = 0.3) students.
Women with medical and non-medical higher 
education who have at least one child
The analysis of the survey has showed that folic acid prior 
to conception was supplemented by only 53.3% of mothers 
that graduated from medical faculties compared to 45% of 
mothers that graduated from non-medical faculties (Figure 2). 
However, the difference between the two groups is not sta-
tistically significant (p = 0.4). During pregnancy in turn 100% 
of mothers with medical education supplemented folic acid 
compared to 83.3% of mothers with non-medical education. 
This difference is statistically significant (p < 0,001).
The group of mothers with medical education includes 
female doctors who worked in the center of NTDs treatment. 
If the pregnancy started after the female doctors had begun 
to work in the center, folic acid was supplemented in all cases 
with no exception. In turn, if the pregnancy started before 
the employment at the center, only 37.5% of pregnancies 
were preceded by folic acid intake. 
Mothers of neonates born with the NTD
The proportion of mothers that supplemented folic 
acid prior the conception and gave birth to a neonate with 
NTD treated at Polish Mother’s Memorial Hospital Research 
Institute in Łódź between 2004–2009 and between 2010–
2015 was 26% and 45.2%, respectively (Table 1). Yet, the 
difference between the groups in time is not statistically 
significant (p = 0.07). Folacin was supplemented during 
pregnancy by 92% of mothers who gave birth to a child 
with NTD in 2004–2009 and 96.8% in 2010–2015. The time 
difference is not statistically significant either (p = 0.38). 
DISCUSSION
Our results indicate that less than a half of female 
non-medical students of universities in Łódź know about 
the need of periconceptional folic acid intake. This situa-
tion did not change across the years 2008–2013. In con-
trast, awareness of NTDs prophylaxis in female medical 
students is high. However, only more than half of mothers 
with medical education used folacin before pregnancy. It 
is worth mentioning that this group includes medical doc-
Figure 1. Level of knowledge concerning prophylaxis of NTDs in 
female students
Female medical
students
Felame students who knew the prophylaxis of NTDs [%]
Female non-medical
students
2008
2013
100
80
60
40
20
0
[%
]
92.9 93.9
35.3
41.1
Figure 2. Supplementation of folic acid in a group of mothers with 
medical and non-medical education
Mothers with
medical education
Felame students who knew the prophylaxis of NTDs [%]
Mothers with
non-medical education
Before pregnancy
During pregnancy
100
80
60
40
20
0
[%
]
53.3
100.0
45.0
83.3
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tors that are residents in pediatrics, neonatology, gynecol-
ogy and obstetrics. There were no significant differences 
with regard to NTDs prophylaxis prior to pregnancy onset 
between groups of women that graduated from medical 
compared to non-medical faculties of universities in Łódź. 
Pre-conceptional folic acid intake was similar in both medi-
cal and non-medical education groups. Yet, even though 
many women know about the need of periconceptional 
folic acid intake, they do not always supplement it before 
the conception. A possible cause for this may be the high 
percentage of unplanned pregnancies in Poland. A study of 
Woude et al. showed that periconceptional folic acid sup-
plementation during the recommended period was used 
significantly more often by women who planned pregnancy 
[15]. Low compliance with periconceptional folic acid intake 
recommendations may also be associated with inadequate 
knowledge of young women about the character and the 
complications of NTDs. It is worth mentioning that 100% of 
female medical doctors who dealt with children with NTD in 
their practice supplemented folic acid prior to conception.
According to a European study of Fulford et al., only 
45.5% of 651 young women from Poland, France, Belgium 
and Germany who planned pregnancy or who were at the 
early stage of the pregnancy implemented NTDs prophylaxis 
despite the fact that 82.8% of them had known about such 
recommendations [16]. Bitzer et al. revealed that 70% of 
respondents to his survey (22925 women of reproductive 
age from 18 European countries) have heard about folic acid 
but only 7% of all women, 28% of women planning preg-
nancy and 55% of pregnant women used folacin [17]. Also, 
the percentage of women who knew what the prophylaxis 
of folic acid is used for was very low (17%). The results of 
other surveys conducted in European countries show similar 
results. According to a Danish project only 10.4% of women 
complied with the recommendations of periconceptional 
prophylaxis, while for Ireland and Spain the proportion is 
24.7% and 19.2%, respectively [18–20]. Reports of EUROCAT 
(2009, 2013) showed that the supplementation of folic acid 
in the recommended period before planned pregnancy was 
used by more than 40% of women only in Holland, Norway 
and United Kingdom. Other countries had considerably 
lower rates [21–22]. 
Only a few studies describe the education level of Polish 
women with regard to NTDs prophylaxis. According to Bagłaj 
and Wojtyłko, only 17.8% of 894 mothers of neonates hos-
pitalized at the Department of Pediatric Surgery and Urol-
ogy between 2001 and 2010 had used folic acid before the 
pregnancy [23]. Only 35.8% of mothers in 2010 and 7.1% of 
mothers in 2001 complied with recommendations of NTDs 
prophylaxis. Women with higher education supplement 
folate most often (37.8%). Twenty-eight percent of mothers 
did not supplement folic acid despite their adequate knowl-
edge about it. Among mothers of children with NTD, only 
13.5% supplemented folacin in the preconceptional period. 
By comparison, our study reports that 26% of women who 
gave birth to a child with NTD in the similar period of time, 
supplemented folic acid before pregnancy. We observed no 
significant difference in folic acid use before and during the 
pregnancy in the groups of mothers of NTD neonates born 
between 2004–2009 and between 2010–2015. 
The review of the literature together with this paper 
shows that the number of young women who supplement 
folic acid is unsatisfactory. Some women do not comply 
with the NTDs prophylaxis because they do not know the 
principles of it. However, a significant proportion of women 
in reproductive age do not supplement folic acid despite 
their knowledge. The reason for this may be inadequate 
awareness about quality of life of patients with NTDs. It is 
probably an important factor behind the inadequate effi-
cacy of programs promoting prophylaxis of NTDs in many 
countries around the world. According to reports of EURO-
CAT (2009 and 2013), the projects conducted by countries 
of the European Union fell short of expectations [21, 22]. 
The majority of countries included in the study recorded 
no satisfactory decrease in incidence of NTDs. Although 
a decrease of live births of neonates with such defects was 
Table 1. Folic acid supplementation in mothers of children with the NTD and additional information from questionnaire
Mothers of children with the NTD 
born between 2004 and 2009
Mothers of children with the NTD 
born between 2010 and 2015 p value
Number 50 31
Folic acid at least 6 weeks before conception 13 (26%) 14 (45.2%) 0.07
Folic acid during pregnancy 46 (92%) 30 (96.8%) 0.38
Informed by a gynaecologist about need of folic 
acid supplementation 22 (44%) 24 (77.4%) 0,003
Prenatal tests during pregnancy 31 (62%) 31 (100%) < 0,001
Smoking during pregnancy 13 (26%) 1 (3.2%) 0.008
Alcohol intake during pregnancy 4 (8%) 0 (0%) 0.11
Infection during pregnancy 11 (22%) 16 (51.6%) 0,006
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observed, it was associated with better prenatal diagnostics 
and termination of pregnancies rather than with effective 
primary prophylaxis. 
Obeid et al. went a step further and called the occur-
rence of NTDs in Europe an epidemy, since it is 1.6 fold higher 
compared to countries that fortify food with folic acid [24]. 
The authors concluded that high prevalence (7478 out of 
approximately 9 million births) of pregnancies with NTDs 
between years 2000–2010 was caused by a failure of Euro-
pean governments to introduce folic acid fortification on 
a population level.
In the United States recommendations concerning peri-
conceptional folic acid intake were implemented in 1992 [25]. 
However, a research survey conducted by Center for Disease 
Control and Prevention (1999) showed that only 25% of wom-
en in reproductive age took folacin [26]. Implementation of 
food fortification with folic acid in 1998 in USA and Canada 
caused a significant decrease of NTDs. The incidence of spina 
bifida decreased by 31% and 53% in the USA and Canada, 
respectively [27, 28]. A study conducted by Ionescu-Ittu et 
al. showed a significant drop in incidence of congenital heart 
defects in Quebec province in Canada after implementation 
of mandatory food fortification [29]. Recently, according to 
the Food Fortification Initiative, such program is being con-
ducted in 79 countries. (http://www.ffinetwork.org/)
Obligatory food fortification with folic acid was not im-
plemented in Europe due to concerns about adverse effects 
in the whole society. Uncontrolled use of folacin in high 
doses may increase the incidence of cancer of large intestine, 
prostate or breast and mask the symptoms of pernicious 
anemia in elderly people [30–32]. However, the experience 
of different European countries and ours indicate that the 
efficacy of implemented educational programs is unsatisfac-
tory and more effort needs to be undertaken to improve the 
compliance with periconceptional folic acid intake. 
For the purpose of this survey we have intentionally 
selected women with higher education since several stud-
ies revealed that such population is most compliant with 
recommendation of folacin supplementation [15, 33]. This 
data suggests that efficacy of the folic acid education cam-
paign in women without university education can be even 
less satisfactory.
The possible limitation of our study is the interviewer 
bias. To minimize it the interviewers used the unified rules 
of asking questions and interpreting the answers. In order 
to avoid selection bias, random sampling was used. 
In summary, compliance with Polish Primary Prevention 
Program of NTDs is unsatisfactory. Only among medical stu-
dents knowledge about the need of periconceptional folic 
acid supplementation is adequate. However, this knowledge 
and the compliance with recommendations do not match. 
Only over a half of mothers with medical education used 
folacin before pregnancy despite their adequate knowledge. 
Folic acid intake was satisfactory in a group of medical doctors 
working in the NTDs treatment center only. Our observation is 
that 100% of pregnancies were preceded by folic acid intake 
when the pregnancy started after the employment in the 
NTDs treatment center, which compares to only 37.5% when 
pregnancy started before the contact with children with NTD. 
Thus, when abandoning the idea of food fortification with 
folic acid, implementation of better educational programs 
with more complete information about NTDs and the qual-
ity of life of children with NTDs should also be considered. 
 CONCLUSIONS 
1. The research survey indicates that the efficacy of educa-
tion program concerning NTDs prophylaxis in Poland 
is unsatisfactory. Even in the group of female medical 
doctors periconceptional folic acid intake was low. Only 
in the group of female doctors who worked in the center 
of NTDs treatment, folic acid supplementation prior to 
conception was at satisfactory level.
2. Compliance with folic acid recommendations may be 
improved by introducing not only the education about 
the prevention of birth defects but also the awareness 
of their consequences in future life.
3. Mandatory food fortification with folic acid, like in other 
countries in the world, is still an open issue.
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